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 ABSTRACT
Background and Objective: Myasthenia gravis (MG) is 
an immune-mediated disorder that can sometimes present 
acutely with a focal neurological deficit and thus mimic a 
cerebrovascular event. The objective of this study was to 
describe the clinical characteristics in a large cohort of pa-
tients who were initially misdiagnosed with an acute vascu-
lar event and later diagnosed with MG.
Methods: This is a retrospective chart review of patients 
who were initially diagnosed with an acute cerebrovascular 
event but subsequently found to have MG. The chart review 
was done for the period from January 2013 to December 
2017, and patients with at least one-year follow-up includ-
ed. Data are reported as means ± SEM, and the results re-
ported using prevalence rates.
Results: Twenty-one patients met our inclusion criteria. 
Among them, 13 (61.9%) were female with a mean age of 
56.7 ± 4.07 years. Ten were MGFA class 3a; seven were 
MGFA class 2b, 3 were MGFA 3b and one was MGFA class 
2a. Eighteen patients were acetylcholine receptor antibody 
positive; one was MuSK positive, and the rest two sero-
negative. Slurred speech (8 patients, 38.1%) was the most 
common symptom that resulted in misdiagnosis, followed 
by hemibody weakness (7 patients, 33.3%) and dysphagia 
(3 patients, 14.3%). Smoking (12 patients, 57.1%) and hy-
pertension (11 patients, 52.4%) were common risk factors 
for cerebrovascular disease. Small vessel disease was sus-
pected the most common etiology (15 patients, 71.4%) of 
the vascular event. Ten patients had received thrombolytic 
therapy, and sixteen patients were on antiplatelets. Four 
patients who presented recurrent symptoms placed on an-
ticoagulants. 
Conclusion: Acute presentation of bulbar symptoms and 
hemibody weakness resulted in the misdiagnosis of MG.  
Keywords: Myasthenia Gravis, Stroke mimics, acute cere-
brovascular event.
Introduction
Myasthenia Gravis (MG) is the most common primary 
disorder of neuromuscular junction (NMJ) transmission. 
Myasthenia gravis is an autoimmune disease in which an-
tibodies bind to receptors at the post-synaptic membrane 
of the neuromuscular junction, inducing various degrees of 
muscle weakness. The annual incidence of MG is 8 to 10 
cases per 1 million persons, and prevalence is 150 to 250 
cases per 1 million making it one of the rare diseases.1 The 
hallmark of the disease is a fluctuating weakness.1-2 In some 
cases, MG can present acutely with focal neurological defi-
cits, thus mimicking an acute cerebrovascular event.3 Previ-
ous studies have included case reports/case series that have 
described acute bulbar weakness in older patients as being 
misdiagnosed as stroke.3,7-8 The objective of this study was 
to describe the clinical characteristics in a large cohort of 
patients who were initially misdiagnosed with an acute vas-
cular event and later diagnosed with MG.
Methods
This is a retrospective chart review of patients diagnosed 
with myasthenia gravis from January 2013 to December 
2017. The inclusion criteria were: 1) Patient’s age > 18 years. 
2) Patients initially diagnosed with an acute cerebrovascular 
event, but the subsequent diagnosis was Myasthenia Gravis. 
3) Patients who have had at least one year follow up. 
Patient demographics, clinical presentation, vascular 
risk factors, type of vascular event, treatment given for the 
vascular event, patient MGFA class at diagnosis, antibody 
status were recorded. Data are reported as means ± SEM, 
and the results reported using prevalence rates. This study 
was approved by the Institutional Review Board (IRB) at 
the University of Missouri, Columbia, MO.
Results
During the study period, 33 patients were identified 
with 21 patients included in the study as they had at least a 
one year follow up. 13 (61.9%) were female, and 8 (38.1%) 
were male. 19 (90.5%) patients were Caucasians with a 
mean age of 56.7 ± 4.07 years. Slurred speech (8 patients, 
38.1%) was the most common symptom that resulted in 
misdiagnosis, followed by hemi body weakness (7 patients, 
33.3%) and dysphagia (3 patients, 14.28%). 18 (85.71%) pa-
tients were acetylcholine receptor antibody positive, and 1 
(4.76%) was MuSK positive, and two were seronegative di-
agnosed based on a repetitive nerve stimulation confirmed 
by single-fiber EMG. These patient demographics and 
characteristics are described below in table 1.
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18 (85.7%) presented to the Emergency room, while 1 
(4.8%) presented to the Primary care practitioner (PCP) 
clinic and 2 (9.5%) to the Neurology clinic. Smoking (12 
patients, 57.1%) and hypertension (11 patients, 52.4%) were 
common vascular risk factors. 
All patients underwent emergent CT-head to rule out 
bleeding. 10 (47.61%) patients acutely treated with intra-
venous tPA. Follow up MRI brain showed no evidence of 
infarct in any of these ten patients. In 10 patients who re-
ceived tPA the duration of symptoms was within 3.5 hours. 
In 11 other patients the duration ranged from 2 to 6 hours 
(median=4 hours).
At the time of follow up in our clinic, 10 (47.61%) pa-
tients were on dual antiplatelets, and 4 (19.04%) patients 
who presented recurrent symptoms were placed on antico-
agulation due to suspicion of cardioembolic etiology while 
seven were on single antiplatelet therapy. CT Angiogram 
(CTA) was subsequently done in all the patients. CTA was 
normal in 15 (71.42%) patients, while 2 (9.1%) each had uni-
lateral chronic carotid artery dissection and extracranial 
vertebral artery stenosis (40% occlusion) and 1 (4.8%) had 
incidental basilar artery aneurysm (20mm in diameter). 
Age (years) 56.7 +/- 4.07 yrs
Sex
(male : female ratio)
8 (38.1%): 13 (61.9%)
Race (Caucasian: 
African-American)
19 (90.5%): 2 (9.5%)
Initial clinical
symptoms- n (%)
Slurred speech - 8 (38.1%)
Hemibody weakness - 7 (33.3%)
Dysphagia - 3 (14.3%)
Ptosis - 2 (9.5%)
Double vision - 2 (9.5%)
Blurred vision - 2 (9.5%)
Dizziness - 1 (4.8%)
Headache - 2 (9.5%)
Wrist drop - 1 (4.8%)
Antibody
Status - n (%)
Acetylcholine - 18 (85.7%)
Musk -1 (4.8%)
Seronegative - 2 (9.5%)
Table 1. Demographics and Clinical Characteristics of the 
Patients (n=21)
Caucasian. Follow-up visits of these patients led to 
the diagnosis of Myasthenia Gravis, in which 10 (47.61%) 
patients were MGFA class 3a, 7 (33.33%) were MGFA 
class 2b, 3 (14.28%) were MGFA class 3b and 1 (4.8%) was 
MGFA class 2a. The characteristics like risk factors, image 
findings, and other variables of the misdiagnosed patients 
shown in table 2. 
The titers of AchR binding antibody ranged from 
8nmol/L to 50nmol/L (mean 20.8nmol/L, normal values< 
or= 0.02nmol/L).4 RNS decrement ranged from 15% to 
55% (mean=25%) with spinal accessory nerve stimulation 
and trapezius recording. 
Mean concentric density with concentric needle elec-
trode and voluntary contraction of extensor digitorum com-
munis ranged from 38 micros in patient 1 and 50 micros in 
patient 2. 
Discussion
Myasthenia Gravis (MG) is most commonly underdi-
agnosed in the elderly (5). The presenting features, espe-
cially bulbar symptoms in the elderly, pose a significant di-
agnostic challenge to the neurologists, as they have a broad 
differential diagnosis. It is also intriguing to note that bulbar 
symptoms can be predominantly seen as an initial presenta-
tion in the elderly, thus posing a diagnostic challenge.5-6
Acute and focal presentations are uncommon in myas-
thenia and have been reported in a few cases in the litera-
ture.7-8 Ocular presentations (diplopia, ptosis) are the most 
common focal presentations seen in almost 53% of myas-
thenia gravis patients. The next common is the focal bulbar 
symptoms presenting as either dysphagia or dysarthria is 
seen around 28% of myasthenia patients, but isolated dys-
phagia as presenting complaint is seen only in 6%.9
Our study reported two patients with ptosis misdiag-
nosed as stroke. Ptosis, although commonly seen in myas-
thenia, when presented atypically, could give rise to a di-
agnostic dilemma. In a 58-year-old acute presentation of 
ptosis with facial droop gave rise to the suspicion of stroke.2
In our study, the most common symptom in misdiag-
nosed patients is slurred speech. Fatigability, the character-
istic finding of myasthenia, is not always seen in such bulbar 
symptoms, increasing the chance of misdiagnosis.7-8,12
The focal weakness of extremities as an initial com-
plaint, although rare, occurs in 14% to 27% of myasthenia 
cases8 and can lead to misdiagnosis. In our study 7 patients 
presented with hemibody weakness and one presented with 
wrist drop. Cerebrovascular events are on the rise in young-
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Variables Patients n=21
CT Angiography findings  Normal 15 (71.4%)
  Vertebral dissection 1 (4.8%)
  Basilar aneurysm 1 (4.8%)
  Carotid dissection 2 (9.5%)
  Vertebral occlusion 2 (9.5%)
Treatment for Stroke n (%)  
  Anti-platelets 16 (76.2%)
  Anticoagulant 4 (19%)
            Endovascular Treatment  1 (4.8%)
  None 3 (14.3%)
Place of presentation n (%)  
  Emergency Room 18 (85.7%)
  Primary care physician 1 (4.8%)
  Neurology Clinic 2 (9.5%)
Stroke risk factors n (%)  
  Hyperlipidemia 2 (9.5%)
  Smoking 12 (57.1%)
  Hypertension 11 (52.4%)
  Diabetes Mellitus  4 (19%)
How MG was subsequently diagnosed n (%)  
       Positive antibody titers: 8nmol/L to 50nmol/L 
(mean 20.8nmol/L)
19 (90.5%)
  Repetitive nerve stimulus 18 (85.7%)
  Single fiber electromyography 2 (99.5%)
MGFA Class n(%)    
  2a 1 (4.8%)
  2b 7 (33.3%)
  3a 10 (47.6%)
  3b 3 (14.3%)
Table 2. Characteristics of the Misdiagnosed Population
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er patients,10 thus posing diagnostic challenge when pa-
tients present with acute symptoms to the emergency room. 
An isolated symptom of diplopia is seen in 50% and 
dysphagia in 15% of myasthenia patients. In our study co-
hort, two patients presented with diplopia and two with 
dysphagia. In one previous case report, myasthenia present-
ed with diplopia secondary to unilateral abducens nerve 
palsy.11 Dysphagia with dysarthria reported in an elderly pa-
tient with myasthenia got misdiagnosed as a stroke due to 
the high index of suspicion.12
Symptoms like dizziness though uncommon, was re-
ported in addition to other constellation of symptoms like 
facial palsy and leg weakness in a patient misdiagnosed as 
Stroke.13
Headache, though occasionally reported as an initial 
complaint in myasthenia patients, could be secondary form 
the concomitant ocular complaints like diplopia. In a ret-
rospective study of 184 Myasthenia patients, tension-type 
headache is reported in 38.6% and migraine headache in 
4.9%.14
The limitations of our study are, the cohort is only from 
our emergency department, and we are unaware of the true 
extent of the misdiagnosis. Also, we cannot entirely rule out 
the overlapping vascular events at the time of presentation, 
which makes the diagnosis complicated. 
Conclusion
Acute presentation of bulbar symptoms and focal 
weakness in patients with vascular risk factors resulted in 
the misdiagnosis of myasthenia gravis as a cerebrovascular 
event.
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govindarajanr@health.missouri.edu
References
1 Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, 
Verschuuren JJGM. (2019). Myasthenia gravis. Nat Rev 
Dis Primers. 2;5(1):30. doi: 10.1038/s41572-019-0079-y.
2 Golden SK, Reiff CJ, Painter CJ, Repplinger MD. 
(2015). Myasthenia Gravis Presenting as Persistent Unilat-
eral Ptosis with Facial Droop. J Emerg Med. 49(1):e23-5. 
doi: 10.1016/j.jemermed.2015.01.002
3 Shaik S, Ul-Haq MA, Emsley HC. (2014). Myasthe-
nia gravis as a ‘stroke mimic’--it’s all in the history. Clin Med 
(Lond). 14(6):640-2. doi: 10.7861/clinmedicine.14-6-640.
4 https://www.mayocliniclabs.com/test-catalog/Clinic
al+and+Interpretive/37427. Accessed April 18,2020. 
5 Vincent A, Clover L, Buckley C, Grimley Evans J, 
Rothwell PM. (2003). Evidence of underdiagnosis of myas-
thenia gravis in older people. J Neurol Neurosurg Psychia-
try. 74(8):1105-8. Doi: 10.1136/jnnp.74.8.1105
6 Alkhawajah NM, Oger J. (2013). Late-onset myas-
thenia gravis: a review when incidence in older adults keeps 
increasing. Muscle Nerve. 48(5):705-10. doi: 10.1002/
mus.23964.
7 Chandra A, Pant B. (2019). Hypophonia as only pre-
senting symptom in myasthenia gravis - a diagnostic di-
lemma in poor countries: a case report. J Med Case Rep 
2;13(1):48. doi: 10.1186/s13256-019-1970-6.
8 Montero- Odasso. (2006). Dysphonia as first symp-
tom of late-onset myasthenia gravis. J Gen Intern Med. 
21(6):C4-6. DOI: 10.1111/j.1525-1497.2006.00343.x
9 Tsung K, Seggev JS. (1995). An unusual cause of dys-
phagia. West J Med. 163(2):159-60.
10 Ekker MS, Boot EM, Singhal AB, Tan KS, De-
bette S, Tuladhar AM et al. (2018). Epidemiology, aetiol-
ogy, and management of ischaemic stroke in young adults. 
Lancet Neurology. 17(9):790-801. doi: 10.1016/S1474-
4422(18)30233-3.
11 Feuer H, Jagoda A. (2001) Myasthenia gravis pre-
senting as a unilateral abducens nerve palsy. Am J Emerg 
Med.19(5):410-2.
12 Kleiner-Fisman G, Kott HS. (1998). Myasthenia 
gravis mimicking stroke in elderly patients. Mayo Clin 
Proc.73(11):1077-8.
13 Libman R, Benson R, Einberg K. (2002). Myasthenia 
mimicking vertebrobasilar stroke. J Neurol. 249(11):1512-
4. Doi: 10.1007/s00415-002-0858-2
14 Tongo O, Delfiner L, Herskovitz S. (2018). 
Pain,Headache, and Other Non-motor Symptoms in My-
asthenia Gravis. Curr Pain Headache Rep. 3;22(6):39. doi: 
10.1007/s11916-018-0687-3.
